Patrick J. Lord - Dec 14, 2023 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Signature
Marta Woods by Power of Attorney
Stock symbol
LRCX
Transactions as of
Dec 14, 2023
Transactions value $
-$957,089
Form type
4
Date filed
12/15/2023, 01:30 PM
Previous filing
Nov 27, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $639K +2.13K +34.32% $300.33 8.33K Dec 14, 2023 Direct F1, F2
transaction LRCX Common Stock Sale -$1.6M -2.13K -25.55% $750.09 6.2K Dec 14, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -2.13K -100% $0.00* 0 Dec 14, 2023 Common Stock 2.13K $300.33 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2023.
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.29, inclusive.
F4 The stock options will become exercisable in three equal installments on 3/2/2021, 03/2/2022, and 3/2/2023.